{"nct_id":"NCT02691325","title":"Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2016-03-14","start_date_type":"ACTUAL","primary_completion_date":"2016-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}